Weight loss jabs slash alcohol hospitalisations by 60%, new study finds

Recent findings reveal a significant connection between weight-loss medications like Wegovy and Mounjaro and a 60% reduction in hospital admissions for alcohol-use disorder. This breakthrough suggests that these drugs might not only help with weight management but also play a crucial role in reducing alcohol dependency, which could transform treatment approaches for those struggling with both issues. The implications are profound, potentially leading to more effective dual-purpose therapies for conditions that often co-occur.